Platelets, petechiae, and preservation of the vascular wall.
作者信息
Nachman Ralph L, Rafii Shahin
机构信息
Weill Cornell Medical College, New York, NY 10065, USA.
出版信息
N Engl J Med. 2008 Sep 18;359(12):1261-70. doi: 10.1056/NEJMra0800887.
Abstract
摘要
相似文献
1
Platelets, petechiae, and preservation of the vascular wall.血小板、瘀点与血管壁的维持
N Engl J Med. 2008 Sep 18;359(12):1261-70. doi: 10.1056/NEJMra0800887.
2
Human megakaryocyte biology and pathophysiology.人类巨核细胞生物学与病理生理学
Crit Rev Oncol Hematol. 1995 Nov;21(1-3):135-57. doi: 10.1016/1040-8428(94)00171-5.
3
Platelets and the vascular wall.血小板与血管壁。
N Engl J Med. 2008 Dec 18;359(25):2727-8; author reply 2728. doi: 10.1056/NEJMc082157.
4
The effect of viral infections on platelets and megakaryocytes.病毒感染对血小板和巨核细胞的影响。
Semin Hematol. 1994 Oct;31(4):329-37.
5
Unraveling mechanisms that control platelet production.解析控制血小板生成的机制。
Semin Thromb Hemost. 2013 Feb;39(1):15-24. doi: 10.1055/s-0032-1331157. Epub 2012 Dec 24.
6
Vascular gap junctions and implications for hypertension.血管间隙连接及其与高血压的关系
Clin Exp Pharmacol Physiol. 2004 Oct;31(10):659-67. doi: 10.1111/j.1440-1681.2004.04071.x.
7
8
Connexin 37 limits thrombus propensity by downregulating platelet reactivity.连接蛋白 37 通过下调血小板反应性来限制血栓形成倾向。
Circulation. 2011 Aug 23;124(8):930-9. doi: 10.1161/CIRCULATIONAHA.110.015479. Epub 2011 Aug 1.
9
Platelets, platelet-derived growth factor, growth control, and their interactions with the vascular wall.血小板、血小板衍生生长因子、生长控制及其与血管壁的相互作用。
J Cardiovasc Pharmacol. 1985;7 Suppl 3:S186-90. doi: 10.1097/00005344-198500073-00022.
10
Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system.不同的网络，共同的生长因子：血管和神经系统的共享生长因子及受体。
Acta Neuropathol. 2007 Jun;113(6):607-26. doi: 10.1007/s00401-007-0228-3. Epub 2007 May 10.
引用本文的文献
1
Analysis of the effect of platelet function and different doses of ticagrelor after flow diverter treatment of intracranial aneurysms.颅内动脉瘤血流导向治疗后血小板功能及不同剂量替格瑞洛的疗效分析
Neurosurg Rev. 2025 Jan 27;48(1):90. doi: 10.1007/s10143-025-03225-6.
2
From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery.从血液到治疗：血小板在癌症靶向药物递送中的革命性应用
J Funct Biomater. 2025 Jan 6;16(1):15. doi: 10.3390/jfb16010015.
3
Whole-genome Sequencing Association Analysis of Quantitative Platelet Traits in A Large Cohort of β-thalassemia.一大群β地中海贫血患者血小板定量性状的全基因组测序关联分析
Genomics Proteomics Bioinformatics. 2025 May 30;23(2). doi: 10.1093/gpbjnl/qzae065.
4
Platelet indices and inflammatory bowel disease: a Mendelian randomization study.血小板指数与炎症性肠病：一项孟德尔随机化研究。
Front Immunol. 2024 Jul 9;15:1377915. doi: 10.3389/fimmu.2024.1377915. eCollection 2024.
5
Mathematical model of aging in COVID-19.新冠病毒感染中衰老的数学模型
J Med Biochem. 2023 Aug 25;42(3):383-391. doi: 10.5937/jomb0-39602.
6
IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapy.IL-10 联合 EASIX 评分可预测抗 CD19 CAR T 细胞治疗后的出血事件。
Ann Hematol. 2023 Dec;102(12):3575-3585. doi: 10.1007/s00277-023-05477-y. Epub 2023 Oct 9.
7
Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures: A Narrative Review.富血小板血浆生物治疗术后血管生成与组织修复取决于血小板剂量及生物制剂策略：一项叙述性综述
Biomedicines. 2023 Jul 6;11(7):1922. doi: 10.3390/biomedicines11071922.
8
Gallium-68 labelled RGD PET/CT imaging of endothelial activation in COVID-19 patients.COVID-19 患者内皮细胞激活的镓-68 标记 RGD PET/CT 显像。
Sci Rep. 2023 Jul 17;13(1):11507. doi: 10.1038/s41598-023-37390-9.
9
Angiotensin II and dengue.血管紧张素 II 与登革热。
Arch Virol. 2023 Jun 27;168(7):191. doi: 10.1007/s00705-023-05814-6.
10
Platelets at the Vessel Wall in Non-Thrombotic Disease.血管壁中的血小板与非血栓性疾病。
Circ Res. 2023 Mar 17;132(6):775-790. doi: 10.1161/CIRCRESAHA.122.321566. Epub 2023 Mar 16.
本文引用的文献
1
Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells.血小板通过与祖细胞和树突状细胞相互作用来调节动脉粥样硬化的发生及动脉粥样硬化斑块的进展。
J Thromb Haemost. 2008 Feb;6(2):235-42. doi: 10.1111/j.1538-7836.2008.02867.x. Epub 2007 Dec 10.
2
Platelet activation and atherothrombosis.血小板活化与动脉粥样硬化血栓形成。
N Engl J Med. 2007 Dec 13;357(24):2482-94. doi: 10.1056/NEJMra071014.
3
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer.贝伐单抗用于铂耐药卵巢癌或腹膜浆液性癌患者的II期研究。
J Clin Oncol. 2007 Nov 20;25(33):5180-6. doi: 10.1200/JCO.2007.12.0782.
4
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released.血管生成受一种新机制调控：促血管生成蛋白和抗血管生成蛋白被分别组织在血小板α颗粒中，并以不同方式释放。
Blood. 2008 Feb 1;111(3):1227-33. doi: 10.1182/blood-2007-09-113837. Epub 2007 Oct 25.
5
Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth.Bcl-2协调内皮细胞与肿瘤细胞之间的相互作用，促进肿瘤生长。
Cancer Res. 2007 Oct 15;67(20):9685-93. doi: 10.1158/0008-5472.CAN-07-1497.
6
Phospho-regulation of Beta-catenin adhesion and signaling functions.β-连环蛋白黏附与信号功能的磷酸化调控
Physiology (Bethesda). 2007 Oct;22:303-9. doi: 10.1152/physiol.00020.2007.
7
Dynamic visualization of thrombopoiesis within bone marrow.骨髓内血小板生成的动态可视化
Science. 2007 Sep 21;317(5845):1767-70. doi: 10.1126/science.1146304.
8
Autocrine VEGF signaling is required for vascular homeostasis.自分泌血管内皮生长因子（VEGF）信号传导是血管稳态所必需的。
Cell. 2007 Aug 24;130(4):691-703. doi: 10.1016/j.cell.2007.06.054.
9
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.接受化疗和贝伐单抗治疗的转移性癌患者的动脉血栓栓塞事件
J Natl Cancer Inst. 2007 Aug 15;99(16):1232-9. doi: 10.1093/jnci/djm086. Epub 2007 Aug 8.
10
Unidirectional crosstalk between Bcl-xL and Bcl-2 enhances the angiogenic phenotype of endothelial cells.Bcl-xL与Bcl-2之间的单向串扰增强了内皮细胞的血管生成表型。
Cell Death Differ. 2007 Sep;14(9):1657-66. doi: 10.1038/sj.cdd.4402174. Epub 2007 Jun 15.
Zotero 插件